Subretinal Injection of tPA Myopic Staphyloma

Show Description +

Frederic Aissani, MD, performs internal limiting membrane peel and subretinal injection of tissue plasminogen activator (tPA) in the single eye of a 75-year-old woman with myopic staphyloma who experienced a sudden loss of vision.

Posted: 11/23/2022

Subretinal Injection of tPA Myopic Staphyloma

Frederic Aissani, MD, performs internal limiting membrane peel and subretinal injection of tissue plasminogen activator (tPA) in the single eye of a 75-year-old woman with myopic staphyloma who experienced a sudden loss of vision.

Posted: 11/23/2022

Please log in to leave a comment.

More in Retina

AI for Ocular Oncology

Maria Berrocal, MD and Zelia Correa, MD, PhD

Aflibercept 8 mg in nAMD: Outcomes After Switching From Faricimab

Ben Young, MD; Pheobe Mellen, MD; and Jordan Deaner, MD

Keeping Patients at the Center of GA Therapy: Motivating Patients, Halting Treatment, and Monitoring Progression

John Kitchens, MD; Margaret Chang, MD, MS; David Eichenbaum, MD; and Ferhina Ali, MD, MPH